Contents

Search


migratory necrolytic erythema; glucagonoma syndrome; erythema necrolytica migrans

Etiology: 1) glucagonoma 2) advanced hepatic cirrhosis 3) bronchial carcinoma 4) idiopathic* (may be related to nutritional deficiency) * rare patients without underlying malignancy [2] Epidemiology: 1) rare 2) middle-aged to elderly Pathology: 1) early skin lesions a) band-like upper epidermal necrosis b) retention of pyknotic nuclei c) pale keratinocyte cytoplasm 2) electron microscopy -> vacuolar degeneration & lysis of organelles Clinical manifestations: 1) intertrigous erythema, epidermal scales, erosions [2] 2) inflammatory plaques enlarge with central clearing, resulting in large areas that become confluent 3) borders with vesiculation to bulla formation, crusting & scaling 4) gyrate, circinate, arcuate & annular arrangement of lesions 5) distribution: a) flexures b) intertriginous areas c) perioral d) perigenital e) fingertips red, shining, erosive 6) mucous membranes a) glossitis b) angular cheilitis c) blepharitis Laboratory: 1) serum chemistries a) hyperglycemia b) glucagon c) serum zinc 2) skin biopsy Differential diagnosis: 1) acrodermatitis enteropathica 2) zinc deficiency 3) pustular psoriasis 4) mucocutaneous candidiasis 5) familial pemphigus Management: 1) responds poorly to all forms of therapy 2) partial response in some cases to zinc replacement 3) surgical excision of glucagonoma may improve or resolve symptoms

General

paraneoplastic dermatosis

References

  1. Color Atlas & Synopsis of Clinical Dermatology, Common & Serious Diseases, 3rd ed, Fitzpatrick et al, McGraw Hill, NY, 1997, pg 512
  2. Medical Knowledge Self Assessment Program (MKSAP) 16, 17, 18. American College of Physicians, Philadelphia 2012, 2015, 2018.